文献速递肺外科

类癌淋巴结转移的发生率与预后意义

Incidence and Prognostic Significance of Carcinoid Lymph Node Metastases.
PubMed 文献 · Ann Thorac Surg · 2018-06-15

基于美国国家癌症数据库2004至2014年数据,分析3335例接受肺切除并清扫至少10枚淋巴结的肺类癌患者,淋巴结转移率为21%,非典型类癌与淋巴结转移均为总生存的独立预测因素,非典型类癌风险比3.25,淋巴结转移风险比2.3。

要点

  • 肺类癌患者淋巴结转移率为21%,其中N1占15%,N2占6%。
  • 肿瘤大小是非典型类癌和典型类癌淋巴结转移的独立预测因素。
  • 淋巴结转移与非典型类癌及典型类癌大于2厘米者的总生存较差相关。

核心结论

  • 相当数量的分期充分的类癌患者存在淋巴结转移,淋巴结受累是总生存较差的独立预测因素。

研究设计与样本

  • 回顾性分析美国国家癌症数据库2004至2014年接受肺切除并清扫至少10枚淋巴结的类癌患者,共3335例,其中典型类癌2893例,非典型类癌442例。

主要发现

  • 淋巴结转移率为21%,其中N1占15%,N2占6%。
  • 淋巴结分期上调率为13%,典型类癌11%,非典型类癌24%。
  • 总生存的独立预测因素包括非典型类癌(HR 3.25,95%CI 2.19-4.78)和淋巴结转移(HR 2.3,95%CI 1.49-3.58)。
  • 典型类癌大于2厘米者,有淋巴结转移的5年总生存为87%,无淋巴结转移者为94%,P=0.005。
  • 非典型类癌有淋巴结转移的5年总生存为58%,无淋巴结转移者为88%,P=0.001;典型类癌小于等于2厘米者,有淋巴结转移的5年总生存为93%,无淋巴结转移者为92%,P=0.67。

临床怎么用

  • 作者认为,对肿瘤大于2厘米及非典型亚型的类癌进行淋巴结清扫可获得重要的预后信息。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Pulmonary carcinoid tumors are often considered indolent tumors. The prognostic significance of lymph node (LN) metastases and the need for mediastinal dissection is controversial. We sought to determine the incidence, risk factors, and prognosis of LN metastases in resected carcinoid patients. METHODS: Patients undergoing lung resection for carcinoid and removal of ≥10 LNs were identified in the National Cancer Database from 2004 to 2014. Typical (TCs) and atypical carcinoids (ACs) were included. Clinical and pathologic LN status was assessed. Overall survival (OS) was analyzed using log-rank test and Cox hazard regression analysis. RESULTS: A total of 3,335 patients (TC 2,893; AC 442), underwent resection (lobectomy/bilobectomy 84%, pneumonectomy 8%, sublobar resection 8%). LN involvement was present in 21% of patients (N1 15%, N2 6%) and increased with tumor size and AC histology. Tumor size was an independent predictor of LN disease. The rate of nodal upstaging was 13% (TC 11%, AC 24%). Independent predictors of OS were AC type (HR 3.25 [95% CI 2.19-4.78]) and LN metastases (HR 2.3 [1.49-3.58]). LN disease was associated with worse survival for TC > 2 cm (5-year OS 87% versus 94%, p = 0.005) and AC (58% versus 88%, p = 0.001), but not for small (≤ 2 cm) TC patients (5-year OS 93% versus 92%, p = 0.67). CONCLUSIONS: A substantial number of well-staged carcinoid patients had LN metastases. Large tumor size is a valuable predictor of carcinoid nodal disease. LN involvement was an independent predictor of worse survival. Nodal dissection in tumors > 2 cm and in atypical subtype can yield important prognostic information.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Kneuertz PJ, Kamel MK, Stiles BM, et al. Incidence and Prognostic Significance of Carcinoid Lymph Node Metastases. Ann Thorac Surg. 2018. PMID: 29908980. doi:10.1016/j.athoracsur.2018.05.044

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。